Miltefosine Failure and Amphotericin B Success in the Treatment of a Case of Cutaneous Leishmania Braziliensis in a Recent Traveler in Belize and Guatemala
We report the case of a 53-year-old male with recent travel to Guatemala and Belize who was diagnosed with cutaneous leishmaniasis (CL). He was treated empirically with miltefosine with no improvement and switched to amphotericin B upon species identification of L. braziliensis, resulting in the res...
Saved in:
| Main Authors: | Michelle Y. Ko, Emilie Fowler, Amanda Scott, Daniel Z. Uslan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Case Reports in Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/crdi/6644758 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial.
by: Paulo R Machado, et al.
Published: (2010-12-01) -
Genomic characterization of Leishmania (V.) braziliensis associated with antimony therapeutic failure and variable in vitro tolerance to amphotericin B
by: Laura Natalia Gonzalez-Garcia, et al.
Published: (2025-04-01) -
Evolutionary genomics of Leishmania braziliensis across the neotropical realm
by: Senne Heeren, et al.
Published: (2024-11-01) -
The efficacy of new 2,5-dihydroxybenzyl derivatives against Trypanosoma cruzi, Leishmania infantum and Leishmania braziliensis
by: Miriam Rolón, et al.
Published: (2019-06-01) -
A novel strain of Leishmania braziliensis harbors not a toti- but a bunyavirus.
by: Alexei Yu Kostygov, et al.
Published: (2024-12-01)